These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2769939)

  • 1. [Study on metabolism of pyridonecarboxylic acid. I. Isolation and identification of metabolites of (+-)-7-(3-amino-1-pyrrolidinyl)-6-fluoro-1- (2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid p-toluenesulfonate hydrate (T-3262) in urine].
    Tai M; Konishi Y; Sugimoto Y; Demachi K; Maeda T
    Jpn J Antibiot; 1989 Apr; 42(4):868-75. PubMed ID: 2769939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on metabolism of pyridonecarboxylic acid II. Determination of metabolites of (+-)-7-(3-amino-1-pyrrolidinyl)-6-fluoro-1-(2,4-difluorophenyl)- 1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid p-toluenesulfonate hydrate (T-3262) in blood, urine, bile, and feces].
    Tai M; Sakai H; Nitta J; Hayakawa H; Sugimoto Y; Hayashi K; Maeda T
    Jpn J Antibiot; 1989 Apr; 42(4):876-86. PubMed ID: 2769940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on absorption, distribution and excretion of 14C labeled (+-)-7-(3-amino-1-pyrrolidinyl)-6-fluoro-1-(2,4-difluorophenyl)-1,4- dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid p-toluene-sulfonate hydrate (14C-T-3262) in rats and mice].
    Maeda T; Sakai H; Hayakawa H; Hayashi K; Yoneda K
    Jpn J Antibiot; 1989 Apr; 42(4):854-67. PubMed ID: 2769938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [General pharmacology of T-3262, a new pyridonecarboxylic acid].
    Hirai S; Hiraiwa T; Arai H; Ono S; Tanaka K; Hashiba K; Nakada Y; Goden K; Tanada K; Maekawa M
    Jpn J Antibiot; 1989 Apr; 42(4):831-53. PubMed ID: 2769937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adverse drug interactions between pyridonecarboxylic acids and nonsteroidal antiinflammatory drugs: convulsion after oral or intracerebral administration in mice].
    Hirai S; Tanaka K; Makino S; Narita H
    Yakugaku Zasshi; 1989 Feb; 109(2):119-26. PubMed ID: 2746470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro and in-vivo activities of T-3262, a new pyridone carboxylic acid.
    Takahata M; Otsuki M; Nishino T
    J Antimicrob Chemother; 1988 Aug; 22(2):143-54. PubMed ID: 3182417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoronaphthyridines as antibacterial agents. 6. Synthesis and structure-activity relationships of new chiral 7-(1-, 3-, 4-, and 6-methyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)naphthyridine analogues of 7-[(1R,4R)-2,5- diazabicyclo[2.2.1]heptan-2-yl]-1-(1,1-dimethylethyl)-6-fluoro-1,4-dihy dro-4-oxo-1,8-naphthyridine-3-carboxylic acid. Influence of the configuration on blood pressure in dogs. A quinolone-class effect.
    Remuzon P; Bouzard D; Guiol C; Jacquet JP
    J Med Chem; 1992 Jul; 35(15):2898-909. PubMed ID: 1322990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of prulifloxacin. 3rd communication: metabolism in rats, dogs and monkeys.
    Okuyama Y; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):293-8. PubMed ID: 9105548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyridonecarboxylic acids as antibacterial agents. 4. Synthesis and antibacterial activity of 7-(3-amino-1-pyrrolidinyl)-1-ethyl-6-fluoro-1,4 -dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid and its analogues.
    Egawa H; Miyamoto T; Minamida A; Nishimura Y; Okada H; Uno H; Matsumoto J
    J Med Chem; 1984 Dec; 27(12):1543-8. PubMed ID: 6438319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of metabolism of T-3761 in animal].
    Tai M; Demachi K; Simizu Y
    Jpn J Antibiot; 1995 May; 48(5):656-64. PubMed ID: 7637200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of (+)-1,4-dihydro-7-(trans-3-methoxy-4-methylamino-1-pyrrolidinyl)-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid (voreloxin; formerly SNS-595), a novel replication-dependent DNA-damaging agent.
    Evanchik MJ; Allen D; Yoburn JC; Silverman JA; Hoch U
    Drug Metab Dispos; 2009 Mar; 37(3):594-601. PubMed ID: 19074528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of new arylfluoronaphthyridine antibacterial agents.
    Chu DT; Fernandes PB; Claiborne AK; Gracey EH; Pernet AG
    J Med Chem; 1986 Nov; 29(11):2363-9. PubMed ID: 3783594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoronaphthyridines and quinolones as antibacterial agents. 2. Synthesis and structure-activity relationships of new 1-tert-butyl 7-substituted derivatives.
    Bouzard D; Di Cesare P; Essiz M; Jacquet JP; Kiechel JR; Remuzon P; Weber A; Oki T; Masuyoshi M; Kessler RE
    J Med Chem; 1990 May; 33(5):1344-52. PubMed ID: 2329555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric synthesis and properties of the enantiomers of the antibacterial agent 7-(3-aminopyrrolidin-1-yl)-1-(2,4-difluorophenyl)-1,4-dihydro-6- fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid hydrochloride.
    Rosen T; Chu DT; Lico IM; Fernandes PB; Shen L; Borodkin S; Pernet AG
    J Med Chem; 1988 Aug; 31(8):1586-90. PubMed ID: 3397996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to the quinolones and fluoroquinolones for the development of generic and specific immunoassays for detection of these residues in animal products.
    Bucknall S; Silverlight J; Coldham N; Thorne L; Jackman R
    Food Addit Contam; 2003 Mar; 20(3):221-8. PubMed ID: 12623645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel fluoroquinolone antibacterial agents containing oxime-substituted (aminomethyl)pyrrolidines: synthesis and antibacterial activity of 7-(4-(aminomethyl)-3-(methoxyimino)pyrrolidin-1-yl)-1-cyclopropyl-6- fluoro-4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid (LB20304).
    Hong CY; Kim YK; Chang JH; Kim SH; Choi H; Nam DH; Kim YZ; Kwak JH
    J Med Chem; 1997 Oct; 40(22):3584-93. PubMed ID: 9357525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyridonecarboxylic acids as antibacterial agents. 2. Synthesis and structure-activity relationships of 1,6,7-trisubstituted 1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids, including enoxacin, a new antibacterial agent.
    Matsumoto J; Miyamoto T; Minamida A; Nishimura Y; Egawa H; Nishimura H
    J Med Chem; 1984 Mar; 27(3):292-301. PubMed ID: 6422043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pyridonecarboxylic acids as antibacterial agents. V. Synthesis and structure-activity relationship of 7-amino-6-fluoro-1-(fluorophenyl)-4-oxo-1,8-naphthyridine-3-carboxylic acids].
    Narita H; Konishi Y; Nitta J; Kitayama I; Miyazima M; Watanabe Y; Yotsuji A; Saikawa I
    Yakugaku Zasshi; 1986 Sep; 106(9):802-7. PubMed ID: 3795003
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis and antibacterial activity of new quinolones containing a 7-[3-(1-amino-1-methylethyl)-1-pyrrolidinyl] moiety. Gram-positive agents with excellent oral activity and low side-effect potential.
    Hagen SE; Domagala JM; Gracheck SJ; Sesnie JA; Stier MA; Suto MJ
    J Med Chem; 1994 Mar; 37(6):733-8. PubMed ID: 8145222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoronaphthyridines as antibacterial agents. 4. Synthesis and structure-activity relationships of 5-substituted-6-fluoro-7-(cycloalkylamino)-1,4-dihydro-4-oxo-1,8- naphthyridine-3-carboxylic acids.
    Bouzard D; Di Cesare P; Essiz M; Jacquet JP; Ledoussal B; Remuzon P; Kessler RE; Fung-Tomc J
    J Med Chem; 1992 Feb; 35(3):518-25. PubMed ID: 1738144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.